Plain-English translation of NCT06608732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a combination approach for adolescents and adults with B-cell acute lymphoblastic leukemia (a serious blood cancer) who have achieved remission but still show signs of remaining disease. The study combines —a type of cell therapy that trains your own immune cells to fight cancer—with an autologous stem cell transplant, where your own healthy stem cells are collected, preserved, and given back to you. The goal is to see whether this combined approach is safe and effective at preventing the cancer from returning.
Standard treatments for this type of leukemia don't work well enough for all patients, especially those who still have detectable cancer cells after initial chemotherapy. This trial is exploring whether combining a newer immunotherapy with a stem cell transplant might give patients a better chance at long-term survival.
You likely qualify if…
You likely don't qualify if…
You would undergo collection of your stem cells, which are then preserved for later use. You would then receive the new cell therapy (), followed by chemotherapy to prepare your body, and finally the transplant of your stored stem cells. Throughout the process, you would have frequent medical visits, blood tests, and bone marrow checks to monitor your response and watch for side effects. The trial involves about 20 participants total and is being conducted at a research hospital in China.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
China